Skip to main content
Premium Trial:

Request an Annual Quote

Peter Covitz, Matthew Shanahan

Premium
Peter Covitz, chief operating officer for the National Cancer Institute’s Center for Bioinformatics, will leave the NCI at the end of February to join MDS Nordion as senior vice president of Innovation. MDS Nordion is a mid-sized nuclear medicine biotech based in Ottawa, Canada.
 
Covitz worked at the NCICB for six years and played an instrumental role in launching the Cancer Biomedical Informatics Grid project. In a statement posted on the caBIG listserv this week, Kenneth Buetow, director of the NCICB, said that Covitz was “invaluable in guiding many aspects of the initiative — from its core infrastructure to its management, and many components in between.”
 
Buetow said that Covitz’s caBIG duties will be assigned to “interim point people,” who will be disclosed later.
 

 

Authentication software firm BioPassword has appointed Matthew Shanahan as senior vice president of marketing and strategy. Shanahan most recently served as chief marketing officer for Teranode. Prior to that, he was a product manager at Documentum, where he spent 10 years before the company was acquired by EMC. Before that, Shanahan was a manager at Accenture specializing in advanced enterprise architectures for Global 500 companies.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.